Drug strategy 2017
The drug strategy 2017 sets out how the government and its partners, at local, national and international levels, will take new action to tackle drug misuse and the harms it causes.
The strategy builds on our existing approach to preventing drug misuse, supporting people to recover from dependence and restricting the supply of drugs, with new action to:
- promote a smarter, partnership-based approach
- enhance our balanced approach across the 3 existing strands (reducing demand, restricting supply and building recovery) with a fourth strand on global action
- provide stronger governance for delivering the strategy, including a Home Secretary-chaired board and the introduction of a National Recovery Champion
- expand the data we collect on levels of drug misuse and recovery from dependence, and develop a set of jointly-owned outcome measures to drive action across a broader range of local services
The letter to the Advisory Council on the Misuse of Drugs (ACMD) sets out the government’s response to the ACMD’s advice on developing a new drug strategy.
The drug strategy evaluation provides an assessment of the effectiveness and, where possible, value for money of activity delivered under the drug strategy 2010.
The Psychoactive Substances Act review framework sets out the government’s proposed approach to reviewing the Psychoactive Substances Act, and outlines the research questions that the review will aim to examine.
Published 14 July 2017